Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Clozaril

Clozaril
In stock
50mg · 25mg · 100mg
from 30,18 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
62,48 £52,06 £
1,74 £ per tablet

In brief

  • Clozaril (clozapine) is a prescription‑only medicine supplied from licensed pharmacies and, in many countries, only under special distribution/monitoring programmes (e.g. REMS in the US). Buying or using it without a valid prescription and required blood monitoring is illegal and unsafe — it must be prescribed by an authorised clinician and the patient enrolled in a blood‑monitoring scheme.
  • Clozapine is used for treatment‑resistant schizophrenia and to reduce recurrent suicidal behaviour in schizophrenia. It is an atypical (second‑generation) antipsychotic that antagonises dopamine D2 and serotonin 5‑HT2A receptors and interacts with multiple other receptors (muscarinic, histaminic H1, adrenergic), which together produce its antipsychotic effects.
  • Typical adult initiation is 12.5 mg once or twice on day 1, titrated over 2–3 weeks to a usual maintenance range of 300–450 mg/day in divided doses; the maximum recommended dose is 900 mg/day. Elderly patients and those with hepatic/renal impairment require lower starting doses and slower titration.
  • Administration is oral: standard tablets (25 mg, 50 mg, 100 mg, 200 mg), orally disintegrating tablets (ODT) (12.5 mg, 25 mg, 100 mg) and oral suspension (e.g. 50 mg/mL).
  • Some effects such as sedation or drowsiness can appear within hours; meaningful antipsychotic symptom improvement typically begins over 1–2 weeks, with full therapeutic effects often taking several weeks (commonly up to 4–6 weeks).
  • Clozapine is usually given once or twice daily and provides around 24‑hour symptomatic coverage with daily dosing; the elimination half‑life is variable (commonly ~8–12 hours at steady state), so steady state is reached after several days.
  • Do not drink alcohol while taking clozapine — alcohol increases sedation, respiratory depression and orthostatic hypotension and can worsen CNS depression and other adverse effects.
  • The most common side effect is drowsiness/sedation; other frequent effects include sialorrhoea (excess saliva), constipation, tachycardia, orthostatic hypotension, weight gain and dizziness. Serious risks include neutropenia/agranulocytosis (mandatory blood monitoring), seizures and myocarditis.
  • I cannot assist you to obtain Clozaril without a prescription — would you like help arranging a legal prescription and enrolment in the required blood‑monitoring programme so treatment can be provided safely?

Market Realities And Patient Experiences

  • INN (International Nonproprietary Name): Clozapine.
  • Brand Names Available In United Kingdom: Clozaril and generic clozapine products from Sandoz (Novartis), Mylan and Teva.
  • ATC Code: N05AH02.
  • Forms & Dosages: Tablets 25 mg, 50 mg, 100 mg, 200 mg; Orally Disintegrating Tablets (ODT) 12.5 mg, 25 mg, 100 mg; Oral Suspension 50 mg/mL.
  • Manufacturers In United Kingdom: Sandoz (Novartis), Mylan, Teva; additional regional suppliers include Recordati and Medochemie.
  • Registration Status In United Kingdom: Clozaril is available in the UK and is registered as a prescription medicine.
  • OTC / Rx Classification: Prescription only (Rx) in the UK and other major markets due to risk of severe neutropenia and other adverse effects.

Real-World Access And Adherence

Patients often ask how they will manage the monitoring required with clozapine while keeping a job and social life.

Clozapine sits apart from other antipsychotics because many people describe life‑changing symptom control alongside a demanding monitoring schedule.

Blood monitoring is mandatory, and routine testing is weekly for the first six months then every two weeks thereafter.

These checks influence work, travel and confidence in services and are a central part of the clozapine patient experience.

Community pharmacies — both NHS and private — frequently become the first advising point for practical questions about clozapine access and monitoring.

Patients report variability in lab turnaround times and differences between NHS trusts and private providers when it comes to blood result reporting.

That variability can delay dispensing when a recent white cell or ANC result is not available at the time the prescription is presented.

Pharmacists can help by confirming monitoring status, advising on how to access local testing and explaining the blood monitoring requirements for safety.

Practical Patient Pain Points

What usually worries patients most is the logistics: fitting clinic appointments around work and arranging transport to blood tests.

Transport costs and lost hours at work are frequently reported practical barriers to adherence with clozapine monitoring.

There is also stigma linked to taking a medication classified as a “serious” antipsychotic, which affects willingness to continue treatment for some people.

Common troublesome side effects include sedation and sialorrhoea, and these can reduce quality of life if not addressed proactively.

Simple practical solutions that pharmacies can promote include home phlebotomy where available and pharmacist‑led counselling to manage side effects.

Patient journey: Diagnosis → Initiation → Monitoring → Maintenance.

Use of an initiation checklist, appointment reminders and connections with community mental health teams helps patients get started and stay on treatment.

MHRA and NHS guidance require mandatory monitoring and clinician oversight, and this framing helps product pages show empathy and practical help.

Product Snapshot For A Pharmacy Product Page

Core Product Identifiers

Clozapine is listed by INN as clozapine and is commonly known under the brand Clozaril in the UK and globally.

Other brand presentations noted internationally include FazaClo as an orally disintegrating tablet and Versacloz as an oral suspension.

The ATC code for clozapine is N05AH02, and the medicine is prescription only (Rx).

Distribution is controlled in many markets because of the need for mandatory haematological monitoring.

Product pages should clearly show brand and generic options such as Clozaril tablets, clozapine oral suspension and ODT presentations for people with swallowing difficulties.

Presenting clear identifiers and regulatory flags on the product listing builds trust and supports safe dispensing.

Quick Specs For Listing

Dosage Form Strengths Usability Notes
Tablets 25 mg, 50 mg, 100 mg, 200 mg Standard oral tablets supplied in blisters or bottles.
Orally Disintegrating Tablets (ODT) 12.5 mg, 25 mg, 100 mg ODTs dissolve on the tongue and help patients with dysphagia.
Oral Suspension 50 mg/mL Versacloz suspension allows flexible dosing for titration and paediatric/elderly use.

Key specifications include tablet strengths from 25 mg to 200 mg, ODT options and a 50 mg/mL oral suspension presentation.

Products are supplied in child‑resistant bottles or unit‑dose blisters to support safe dispensing routines.

A “Need Blood Monitoring” badge on the product page is recommended so patients see safety obligations before purchase.

Include a link or clear instruction to local monitoring enrolment or shared‑care contacts to reduce barriers at the point of purchase.

Availability, Brands And Local Packaging

Brand Options And Suppliers

Several brands and generics of clozapine are used internationally and in the UK market.

Clozaril is the best known brand name and is listed as available in the UK and globally.

Other brand names recorded in neighbouring markets include Leponex in the EU and Versacloz and FazaClo in the US market.

Manufacturers supplying clozapine include Sandoz (Novartis), Mylan and Teva, alongside regional suppliers such as Recordati and Medochemie.

Pharmacies should note that availability may vary by supplier and that generics are commonly used to manage cost and supply.

Packaging And Presentation

SKU Pack Size Form
Clozaril 25 mg Blister or bottle Tablet
Clozaril 100 mg Blister or bottle Tablet
FazaClo ODT 25 mg Blister Orally disintegrating tablet
Versacloz 50 mg/mL 90 mL bottle Oral suspension

Packaging formats include unit‑dose blisters for daily dosing and child‑resistant bottles for suspensions and multi‑dose supplies.

Versacloz is supplied as a 90 mL bottle at 50 mg/mL and is suitable for titration and patients who need flexible dosing.

Pharmacies should show pack sizes and whether a pack supports dispensing routines such as daily dosing or titration schedules.

Note regulatory flags: distribution is controlled in several markets and pharmacies must observe monitoring programme requirements.

Stock lead times and generic availability influence pricing choices for NHS and private prescriptions, so display estimated lead times on product pages.

Indications And Approved Uses In The UK

Licensed Clinical Indications

What conditions is clozapine approved to treat in the UK?

Clozapine is primarily indicated for treatment‑resistant schizophrenia in adults.

The medicine is also indicated for reducing the risk of recurrent suicidal behaviour in schizophrenia spectrum disorders when appropriate.

Any product page must clearly state these licensed uses and reference local NHS or MHRA guidance for prescribers and pharmacists.

On-Label Vs Off-Label And Prescribing Context

  1. On‑label Indications: Treatment‑resistant schizophrenia; reduction of recurrent suicidal behaviour in schizophrenia spectrum disorders.
  2. Contraindications: See absolute and relative contraindications on product pages and local manuals.
  3. Legal Status: Prescription only (Rx) and controlled distribution in many markets.

Initiation of clozapine is normally undertaken by secondary care psychiatry teams, with maintenance sometimes moved to shared‑care under GP and pharmacy supervision.

Product listings should make clear that initiation criteria must be documented and that maintenance therapy is chronic and requires regular review.

Typical Dosing Regimen And Titration Practicalities

Initiation And Titration

How is clozapine started safely?

Initial dosing commonly begins at 12.5 mg once or twice on day one.

Titration proceeds cautiously, typically reaching a maintenance dose of 300–450 mg per day in divided doses over two to three weeks.

The maximum adult dose recorded is 900 mg per day, but most patients remain well controlled on lower maintenance doses.

Titration must be gradual to reduce the risk of adverse events such as orthostatic hypotension and seizures at higher doses.

Practical Pharmacy Notes

Pharmacies should use a stepwise titration checklist and confirm baseline blood results before each supply during the initiation phase.

Advise patients to report fever, sore throat or signs of infection immediately because neutropenia may present with non‑specific symptoms.

Provide dosing calendar stickers and clear instructions for taking divided doses to support adherence.

ODT tablets dissolve on the tongue and are helpful where swallowing is difficult, while the 50 mg/mL suspension permits fine dose adjustments during titration.

In elderly patients or those with renal or hepatic impairment start lower and titrate more slowly with closer monitoring.

Monitoring: Blood Tests And Safety Programmes

Mandatory Haematological Monitoring

Which blood tests are required and how often?

Clozapine requires mandatory haematological monitoring because of the risk of neutropenia and agranulocytosis.

The standard schedule is weekly blood tests for the first six months then fortnightly thereafter.

Regulatory programmes in multiple markets require prescribers, pharmacies and patients to be enrolled in monitoring schemes prior to supply.

Pharmacy Role And Systems

Time Frame Monitoring Requirement Action For Pharmacists
Initiation (Weeks 0–26) Weekly full blood count and ANC Confirm up‑to‑date result before dispensing.
Maintenance (After 26 weeks) Every two weeks full blood count and ANC Verify monitoring record and log dates/values before supply.

Pharmacies must verify recent ANC/WBC values and test dates before dispensing clozapine and should record the patient’s monitoring number where applicable.

Many UK pharmacies integrate with local community mental health services or use shared‑care forms to streamline verification.

Linking to NHS or MHRA guidance on monitoring and to local laboratories improves safety and reduces delays for patients.

Emergency procedures must be in place for abnormal counts, including withholding supply and alerting the prescriber and haematology services.

Side Effects — Common, Bothersome And Severe Risks

Common And Quality-Of-Life Side Effects

Which side effects do patients worry about most with clozapine?

Mild to moderate side effects commonly include drowsiness, sedation and excessive salivation (sialorrhoea).

Other frequent effects are tachycardia, orthostatic hypotension, constipation, weight gain, tremor and blurred vision.

Constipation requires active prevention as it can be serious if neglected and is a common reason for pharmacist intervention.

Discussing strategies such as hydration, dietary fibre and prophylactic laxatives helps address quality‑of‑life concerns and supports adherence.

Serious Risks Requiring Action

Event Severity Immediate Action
Agranulocytosis/Neutropenia Severe Stop clozapine and refer to prescriber/haematology immediately.
Seizures Serious (dose‑related) Review dose; seek urgent medical review.
Myocarditis/Cardiomyopathy Potentially Life‑Threatening Urgent cardiology assessment and stop drug if suspected.

Pharmacists should counsel patients to stop the medication and seek urgent care for fever, signs of infection, chest pain or unexplained breathlessness.

Proactive constipation management and seizure precautions at higher doses reduce the likelihood of adverse outcomes.

Contraindications And Cautionary Conditions

Absolute Contraindications

Do not supply clozapine in patients with known hypersensitivity to clozapine or excipients.

Severe neutropenia or agranulocytosis is an absolute contraindication unless managed under specialist guidance.

Uncontrolled epilepsy, severe CNS depression or a history of clozapine‑induced myocarditis are other absolute contraindications.

Conditions Needing Close Monitoring

  • Liver, renal or significant cardiac disease require close monitoring and liaison with the prescriber.
  • A history of seizures or epilepsy is a relative contraindication and needs specialist input.
  • Prostatic hypertrophy, glaucoma, gastrointestinal obstruction and diabetes are conditions where extra vigilance is needed.

Pharmacists should communicate with the initiating psychiatrist and document shared‑care agreements before dispensing in complex cases.

Flag patients with these conditions for more frequent review and ensure requested baseline ECG and liver function tests are available if required by prescribers.

Drug Interactions And Pharmacology Basics

Key Interaction Mechanisms

Clozapine is predominantly metabolised via CYP1A2, with contributions from CYP3A4 and CYP2D6.

CYP1A2 inhibitors such as fluvoxamine or ciprofloxacin can raise clozapine plasma concentrations and increase toxicity risk.

Conversely, inducers such as carbamazepine or heavy smoking reduce plasma concentrations and may reduce efficacy.

Abrupt smoking cessation commonly increases clozapine levels and can precipitate toxicity if doses are not adjusted.

Practical Interaction Checks

Co‑Medication Risk Pharmacy Action
Fluvoxamine, Ciprofloxacin Increase clozapine levels Advise prescriber and consider therapeutic drug monitoring.
Carbamazepine, Smoking Decrease clozapine levels Warn about loss of effect and coordinate dose changes with prescriber.
Benzodiazepines, Opioids Additive sedation and respiratory depression Advise on fall risk and respiratory monitoring.

Include an interaction checklist on product pages to flag high‑risk co‑medications and prompt clinicians to consider drug level testing.

Ensure patients are counselled about the effect of smoking changes and the need to notify prescribers if antibiotics are started.

Special Populations — Elderly, Pregnancy, Renal/Hepatic Impairment

Age And Frailty Considerations

Prescribers should start elderly patients at lower doses, for example 12.5 mg once daily, and titrate slowly.

Older adults are more susceptible to orthostatic hypotension, sedation and risk of falls, so extra monitoring is required.

Pharmacists should reinforce fall prevention advice and liaise with the care team regarding dose adjustments.

Pregnancy, Renal And Hepatic Issues

Population Recommendation
Pregnancy Use only if benefits justify risks; liaise with obstetrics and psychiatry.
Renal Impairment Start at lower doses and monitor more frequently; avoid if severe.
Hepatic Impairment Lower initial dose; avoid in severe impairment and monitor liver function.

Clozapine is not approved for use in children under 18 due to insufficient data.

Document shared‑care arrangements and plan neonatal monitoring if clozapine is continued in pregnancy.

Storage, Dispensing And Packaging Details

Practical Storage And Handling

Store clozapine at room temperature, typically 15–30°C, away from moisture and light.

Keep the medicine in its original packaging and out of reach of children.

Ensure secure transport and avoid exposure to high humidity which can affect product integrity.

Dispensing Controls And Distribution

  • Verify the patient is enrolled in the monitoring programme and that recent blood tests are acceptable before dispensing.
  • Use child‑resistant bottles and unit‑dose blisters as supplied and include label prompts such as “Blood monitoring required”.
  • Record keeping: maintain a dispensing log to support audit and shared‑care compliance.

In markets with controlled distribution, pharmacies must check monitoring numbers and treatment status as part of routine supply.

Missed Doses, Overdose Advice And Emergency Guidance

Missed Dose Actions

If a patient misses a dose and it has been less than 48 hours, they should take it as soon as they remember.

They must not double the next dose to make up for missed medication.

If a missed period exceeds 48 hours the guidance is to restart at the initial dose and retitrate under supervision.

Pharmacists should provide clear written instructions about missed doses and ensure patients know when to seek clinical advice.

Overdose And Emergency Steps

Signs of overdose include marked sedation, delirium, respiratory depression and possible cardiac arrhythmias.

For severe symptoms call emergency services and liaise with toxicology and mental health crisis teams as appropriate.

Pharmacies should supply clear emergency contact details and explain that urgent care is needed for fever, severe constipation, seizures or chest pain.

Pricing, Reimbursement And Where To Buy In The UK

NHS Vs Private Dispensing

On the NHS clozapine is prescription only and may be supplied via secondary care clinics or community pharmacies under shared‑care agreements.

Prescription charges vary by nation within the UK, with Scotland, Wales and Northern Ireland generally offering free prescriptions to eligible patients.

Price differences exist between branded Clozaril and generic clozapine preparations, and generics are often used to manage costs for NHS prescribing.

Retail Channels And Online Pharmacies

Hospital clinics, community pharmacies and online pharmacies are common routes to obtain clozapine, but all must verify monitoring records prior to supply.

National chains and independent pharmacies dispense clozapine but require evidence of up‑to‑date blood monitoring and enrolment in monitoring programmes.

In our online pharmacy, clozaril is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Ensure any online seller advertises compliance with MHRA and local shared‑care requirements before promoting purchase.

Counselling Points, Adherence Aids And Support Services

Essential Pharmacist Counselling

Key counselling topics include the blood monitoring schedule and the importance of reporting fever or signs of infection immediately.

Explain common side effects such as sedation and sialorrhoea and provide practical measures to reduce their impact.

Advise on administration differences for ODTs and suspensions and on interactions such as the effect of smoking on clozapine levels.

Tools And Support Pathways

  • Provide dosing charts, blister packs or calendar stickers to support adherence.
  • Offer SMS or phone reminders for blood tests and pharmacist‑led follow‑ups linked to community mental health teams.
  • Maintain printable patient leaflets that include emergency contacts, monitoring numbers and escalation pathways.

Local support services such as crisis teams, clozapine clinics and national mental health charities should be signposted on product pages to help patients get timely assistance.

Delivery Across United Kingdom

City Region Delivery Time
London Greater London 5-7 days
Birmingham West Midlands 5-7 days
Manchester Greater Manchester 5-7 days
Leeds West Yorkshire 5-7 days
Glasgow Scotland 5-7 days
Edinburgh Scotland 5-7 days
Bristol South West England 5-7 days
Newcastle Upon Tyne North East England 5-9 days
Sheffield South Yorkshire 5-9 days
Cardiff Wales 5-7 days
Belfast Northern Ireland 5-9 days
Southampton South East England 5-9 days
Norwich East of England 5-9 days
Plymouth South West England 5-9 days

Related products